CABA · Forms 3, 4, 5
Insider trades at Cabaletta Bio, Inc.
No open-market insider buys or sells at Cabaletta Bio, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Cabaletta Bio, Inc. (CABA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Cabaletta Bio, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Shawn Tomasello | Director | Options or other derivatives | Form 4 | ||||
| Mark Simon | Director | Options or other derivatives | Form 4 | ||||
| Richard C Henriques Jr | Director | Options or other derivatives | Form 4 | ||||
| Catherine Bollard | Director | Options or other derivatives | Form 4 | ||||
| Scott C. Brun | Director | Options or other derivatives | Form 4 | ||||
| Arun Das | Chief Business Officer | Options or other derivatives | Form 4 | ||||
| Michael Gerard | General Counsel | Options or other derivatives | Form 4 | ||||
| Gwendolyn Binder | President, Science & Tech. | Options or other derivatives | Form 4 | ||||
| David J. Chang | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Steven Nichtberger | President & CEO | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.